Jci_page_head_homepage_01 Jci_page_head_homepage_02
Mahtab Moayeri, Diana Haines, Howard A. Young, Stephen H. Leppla
Published in Volume 112, Issue 5
J Clin Invest. 2003; 112(5):670–682 doi:10.1172/JCI17991
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 4

Histopathological analysis of LT-treated BALB/cJ bone marrow. (a) Diaphyseal marrow from PA-treated (48 hours) control. 40× objective. (b) A mild degree of individual cell death in diaphyseal marrow at 6 hours after LT treatment. 40× objective. (c) A moderate degree of individual cell death in diaphyseal marrow at 18 hours. 40× objective. (d) Metaphyseal (right) and epiphyseal (left) marrow in PA-treated (48 hours) control. 10× objective. (e) Necrosis of metaphyseal marrow (right) with sparing of epiphyseal marrow (left) at 48 hours after LT treatment. 10× objective. (f) Necrosis of metaphyseal bone marrow at 48 hours. 40× objective. Dosage was 100 μg PA (control) or 100 μg LT.